Thus TWEAK increases PLA2R expression in human podocytes, a response prevented by tacrolimus [11], while IL-17 drives the formation of kidney tertiary lymphoid organs in primary glomerular disease, a feature associated with high circulating CXCL13 levels [40]. Here, CXCL13 is linked to glomerular disorder.